A team of Ottawa researchers is getting ready to launch a new series of clinical trials following a significant investment from the private sector.

On Wednesday, Turnstone Biologics Inc. announced it had received a $41.4 million dollar investment from venture capital firms in the United States. The start-up was launched last year by a team of researchers after about 15 years of research into viral therapy for cancer patients.

Dr. John Bell has been leading the research team out of the Ottawa Hospital. He said the investment comes at a critical time for his team.

“This investment allows us to move things forward but it really started with donations from people in Ottawa and across the country who have donated to our research over the years,” he said.

Read the full story at ottawa.ctvnews.ca.